必存 ®，由先声药业生产，是国内第一家获准上市的 依达拉奉注射液，适应症为用于改善急性脑梗塞所致的神经症状、日常生活活动能力和功能障碍。 本品为无色至微黄色（或微黄绿色）的澄明液体。 用于改善急性脑梗塞所致的神经症状、日常生活活动能力和功能障碍。 依达拉奉治疗ALS（肌侧索萎缩硬化症）的III期临床研究已在日本、韩国完成，截至2015年12月，ALS作为新适应症进入日本、韩国依达拉奉说明书，同年美国FDA和欧洲药品管理局分别批准依达拉奉位治疗ALS的 …

用于改善急性脑梗塞所致的神经症状、日常生活活动能力和功能障碍。 一次30mg，每日2次，加入适量生理盐水中稀释后静脉滴注，30分钟内滴完，一个疗程为14天以内。 尽可能在发病后24小时内开始给药。 据日本临床病例569例观察，26例 (4.57%)出现不良反应。 主要表现为肝功能异常16例 (2.81%)，皮疹4例 (0.70%)。 569例中临床检测值异常变化的有122例 (21.4%)，主要是AST上升7.71% (43/558)、ALT上升8.23% (46/559)等肝功能检测值异常。 严重不良反应有： …

As the first edaravone solution for injection marketed in China, BICUN ® is a representative pharmaceutical of free radical scavengers and anti-oxidant. It can improve the neurological …

2023年1月26日 · BiCNU (carmustine) is a cancer (antineoplastic) medication used to treat brain tumors, Hodgkin's disease, multiple myeloma, and non-Hodgkin's lymphoma, and is sometimes given with other cancer medications. What Are Side Effects of BiCNU? Bicnu may cause serious side effects including:

Carmustine is one of the nitrosoureas indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in treatment of brain tumors, multiple myeloma, Hodgkin's disease, and non-Hodgkin's lymphomas.

2024年6月12日 · Carmustine is used in adults alone or in combination with other cancer treatments to treat brain tumors, Hodgkin's disease, multiple myeloma, and non-Hodgkin's lymphoma. Carmustine may also be used for purposes not listed in this medication guide.

Indicated for newly-diagnosed high-grade glioma as an adjunct to surgery and radiation. CrCl 46-80 mL/min: Administer 80% of regular dose. CrCl 31-45 mL/min: Administer 75% of regular dose. CrCl ≤...

It works by slowing or stopping the growth of cancer cells. This medication is given by slow injection into a vein by a health care professional. It is given as directed by your doctor, usually...

BiCNU® (carmustine for injection) is one of the nitrosoureas used in the treatment of certain neoplastic diseases. It is 1,3-bis (2-chloroethyl)-1-nitrosourea. It is sterile lyophilized pale yellow...

2022年6月7日 · 致畸敏感期毒性试验中，妊娠大鼠静脉给予依达拉奉3、30、300mg/kg，300mg/kg组母鼠摄食量下降，体重增加减缓，给药后出现伏卧、步态不稳、自发运动减少、流泪等；各剂量组雄性胎仔体重及30mg/kg组雌性胎仔体重均低于对照组；各剂量组胎仔内脏畸形率升高，幼鼠耳廓展开、眼睑开裂、睾丸下垂、阴道开口有延迟倾向。 妊娠新西兰白兔静脉注射给予依达拉奉3、20、100mg/kg，100mg/kg组动物出现尿液橙褐色、步态失调、流泪、 …